HARPNET is training Europe’s next generation of researchers to understand how inflammation resolves and translate that knowledge into innovative therapies.
Now recruiting 15 Doctoral Candidates across Europe · One application · rank up to three projects
Doctoral projects
Institutions
Countries
Research themes
Each project is a four-year, fully-funded PhD in Resolution Pharmacology, hosted by a European university, hospital or company.
Healthy inflammation ends itself through an active repair phase. When that phase fails, disease begins. HARPNET works on making it succeed.
Inflammation that never switches off drives chronic disease. Rheumatoid arthritis doesn’t stay in the joints, it damages the heart and blood vessels too.
Activate the body’s pro-resolving mediators, receptors and pathways to restore balance and repair tissue, without shutting down its defence against infection.
New therapeutic candidates, biomarkers and a shared RA-ATLAS, plus 15 researchers trained across academia, the clinic and industry.
